Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1991-8-21
|
pubmed:abstractText |
Previous ex vivo studies have provided indirect evidence that the dopamine (DA) metabolite 3-methoxytyramine (3-MT) may be a useful index of DA release in vivo. In the present study, in vivo microdialysis was utilized to assess directly the relationship between extracellular DA and 3-MT in the striatum of rats following a variety of pharmacological manipulations. Apomorphine, a DA receptor agonist, produced a rapid, transient decrease in both DA and 3-MT. Conversely, the DA receptor antagonist haloperidol produced a concomitant increase in extracellular DA and 3-MT. Increases in DA and 3-MT were also noted following the administration of the DA uptake inhibitor, bupropion. Local application of tetrodotoxin resulted in the complete elimination of measurable amounts of DA and 3-MT in the dialysate, gamma-Butyrolactone also greatly decreased DA and 3-MT. Finally, d-amphetamine produced a large increase in DA and 3-MT in animals that had been treated previously with gamma-butyrolactone. The Pearson correlation coefficients for DA and 3-MT following these manipulations ranged from 0.87 to 0.97. These data indicate that interstitial 3-MT is an accurate index of DA release. However, when compared with previous ex vivo findings, the present results also suggest that changes in tissue concentrations of 3-MT may not reliably reflect DA release following certain pharmacological manipulations.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/3,4-Dihydroxyphenylacetic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/3-methoxytyramine,
http://linkedlifedata.com/resource/pubmed/chemical/4-Butyrolactone,
http://linkedlifedata.com/resource/pubmed/chemical/Antidepressive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Apomorphine,
http://linkedlifedata.com/resource/pubmed/chemical/Bupropion,
http://linkedlifedata.com/resource/pubmed/chemical/Haloperidol,
http://linkedlifedata.com/resource/pubmed/chemical/Homovanillic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Propiophenones,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrodotoxin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0022-3042
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
57
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
701-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1906527-3,4-Dihydroxyphenylacetic Acid,
pubmed-meshheading:1906527-4-Butyrolactone,
pubmed-meshheading:1906527-Animals,
pubmed-meshheading:1906527-Antidepressive Agents,
pubmed-meshheading:1906527-Apomorphine,
pubmed-meshheading:1906527-Bupropion,
pubmed-meshheading:1906527-Corpus Striatum,
pubmed-meshheading:1906527-Dialysis,
pubmed-meshheading:1906527-Dopamine,
pubmed-meshheading:1906527-Haloperidol,
pubmed-meshheading:1906527-Homovanillic Acid,
pubmed-meshheading:1906527-Kinetics,
pubmed-meshheading:1906527-Male,
pubmed-meshheading:1906527-Propiophenones,
pubmed-meshheading:1906527-Rats,
pubmed-meshheading:1906527-Rats, Inbred Strains,
pubmed-meshheading:1906527-Tetrodotoxin
|
pubmed:year |
1991
|
pubmed:articleTitle |
Interstitial 3-methoxytyramine reflects striatal dopamine release: an in vivo microdialysis study.
|
pubmed:affiliation |
Department of Psychiatry, University of British Columbia, Vancouver, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|